PepGen (PEPG) Income from Non-Controlling Interests (2024 - 2026)
PepGen (PEPG) reported Income from Non-Controlling Interests of -$70000.0 for Q1 2026, down 59.09% on a YoY basis from -$171111.1 in Q1 2025, and down 300.0% sequentially from $35000.0 in Q4 2025.
PepGen (PEPG) Income from Non-Controlling Interests (2024 - 2026) Analysis & Trends
PepGen (PEPG) has 3 years of Income from Non-Controlling Interests data on file, last reported at -$70000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Non-Controlling Interests fell 59.09% year-over-year to -$70000.0; the trailing twelve-month figure through Mar 2026 stood at -$38000.0 (down 353.33% YoY), and the FY2025 full-year result was -$12000.0, down 130.77% from the prior year.
- Income from Non-Controlling Interests retreated to -$70000.0 in Q1 2026, from $35000.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $186000.0 in Q3 2024 to a low of -$90000.0 in Q4 2024.
- A 3-year average of -$4777.8 and a median of -$21000.0 in 2025 frame the typical range for Income from Non-Controlling Interests.
- Peak annual rise in Income from Non-Controlling Interests reached 138.89% in 2025, while the deepest fall reached 120.0% in 2025.
- Tracing PEPG's Income from Non-Controlling Interests over 3 years: stood at -$90000.0 in 2024, then soared by 138.89% to $35000.0 in 2025, then tumbled by 300.0% to -$70000.0 in 2026.
- Business Quant data shows PEPG's Income from Non-Controlling Interests at -$70000.0 in Q1 2026, $35000.0 in Q4 2025, and $18000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | PepGen | 145.09 Mn | 145.09 Mn | - | -70,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -70,000.00 |
| Dec 31, 2025 | 35,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Jun 30, 2025 | -21,000.00 |
| Mar 31, 2025 | -44,000.00 |
| Dec 31, 2024 | -90,000.00 |
| Sep 30, 2024 | 186,000.00 |
| Jun 30, 2024 | -37,000.00 |
| Mar 31, 2024 | -20,000.00 |